Τόμος 1 (1983) – Τεύχος 2 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 1 (1983) – Issue 2– Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Bêta-lactamines: chimie, action, dégradation enzymatique et pharmacocinétique des pénicillines et des céphalosporines

CHARALAMPOS T. Plessas

Πλέσσας, Χ.Τ.: Bêta-lactamines: chimie, action, dégradation enzymatique et pharmacocinétique des pénicillines et des céphalosporines, Epitheorese Klin. Farmakol. Farmakokinet. 2: 137-154 (1983)

bêta-lactamines, pénicillines, céphalosporines

2.         Brotzu, G.: Lav. Ist. igiene Cagliah (1948)

3.         Batchelor et al.: Nature 183: 257 (1959)

4.         Periti, P.:       Co-betalattamine penamiche e cefem penamiche. In: Aggîornamenti di ctiemioterapîa (G. Gialdronr Grassi, G. Grassi eds), p.170, La Goliardica Pavese, Pavia, 1978.

5.         Boyd, D. B., Hermann, R. B., Prestí, D. E., Marsh, Μ. M.: Electronic structures of cephalosporins and penicillins. J, Med. Chem. 18: 408 (1975).

6.         Abraham, E. P.: Pénicillines and cephalosporins: their chemistry in relation to biological activity. In: Topics in Pharmaceutical Sciences, vol. I, p. I, Interscience Publishers, 1968.

7.         Chain, E., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing, J„ Sanders, A. G.: Lancet 2: 226 (1940)

8.         Abraham, E. P„ Chain, E., Fletcher, C. M., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A.: Lancet 2:177 (1941).

9.         Doyle, F. P., Nayler, J. H. C., Smith, H., Stove, E. R.: Some novel acidtable penicillins. Nature 191: 1091 (1961)

10.       Long, A. A, W., Nayler, J. H. G., Smith, H., Taylor, T., Ward, N.: Derivatives of 6-aminopenicillanic acid. J. Chem, Soc. 10: 1920 (1971).

11. Abraham, E. P.: The cephalosporins. Pharm. Rev. 14: 473 (1962).

12.       Murray, B. E., Moellering, P. G. Jr.: The cephalosporins and cephamycin antibiotics: a status report, Clin. Ther, 2; 155 (1979).

13.       Demonthy, J.: Le point de vue du clinicien dans l’usage des céphalosporines. Mëd. et Hyg. 39: 2657 (1981).

14.       Clara, F.: Impressions du 12e Congrès international de chimiothérapie. Mèd. et Hyg, 39: 3953 (1981).

15.       Gringauz, A.: Drugs: how act and why. The G. V. Mosby Co, St Louis, 1978.

16.       Tipper, D. J., Strominger, J. L.: Mechanism of action of penicillin: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc. Nat. Acad. Set. USA 54: 1133 (1965).

17.       Tipper, D. J., Strominger, J. L.: Biosynthesis of peptidoglycan of bacterial cell-wals. XII) Inhibition of cross-linking by penicillin and cephalosporin studies in Staphylococcus aureus in vivo. J. Biol. Chem. 243: 3169 (1968).

18.       Strominger, J. L.: How penicillin kills bacteria: a short history. In: Microbiology (D. Schlessinger ed) p. 177, Washington DC: Am. Soc, Microbiol., 1977.

19.       Blumberg, M., Strominger, J. L.: Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes, Bact. Rev. 38: 291 (1974).

20.      Andreoni, O.: Betalattamine e forme L. In: Aggiornamenti di Chemioterapia 1977 (G. Gialdroni Grassi, C. Grassi eds) p. 96, La Goliardia Pavese, Pavia, 1978.

21.       Tomasz, A., Holtje, J. V.: Murein hydrolases and the lytic and killing action of penicillin. In: Microcbiology (Schlessinger ed) p. 209, Washington DC: Am. Soc. Microbiol., 1977.

22.       Tomasz, A.: The mechanism of the irreversible antimicrobial effects of penicillins. Ann, Rev. Microbiol. 33: 131 (1979).

23.       Abraham: E. P., Chain, E.: An enzyme from bacteria able to destroy penicillins. Nature 146: 837 (1940).

24.       Murray, B. E., Moellering, R. C.: Patterns and mechanisms of antibiotic resistance. Med. Clin. North Am. 62: 899 (1978).

25.       Jack, G. W., Sykes, B. B., Richmond, M. H.: The β-lactamases of Gram-negative bacteria. Postgrad. Med. J. 46 (Supp.h 41 (1970).

26.       Leive, L: The barrier function of gram negative envelope. Ann. N.Y Acad. Sci. 235: 109 (1974).

27.       Richmond, A. S-, Simberkoff, M. S., Schaeffler, S., Ranal, J. J.: Resistance of Staphylococcus to semisynthetic penicillins and cephalosporins. J. Infect. Dis.135: 108 (1977).

28.      Richmond, Μ. H., Sykes, R. B.; The β-lactamases of gramnegative bacteria and their possible physiological role. Adv.Microb.PhysioL 9: 31 (1973).

29.       Price, K. E.: Structure-activity relationships of semisynthetic penicillins. Appf. Microb. 11: 17 (1969)

30.      Marcy, S.M., Klein, J.O.: The isoxazolyl penicillins: oxacillin, cloxacillin and dicloxacillin. Med. Clin. North Am. 54: 1113 (1970).

31.       Butler, K., English, A.R., Briggs, 8-, Gralla, E„ Stebbîns, R.B., Hobbs, D.C.: Indanyl carbenicillin: chemistry and laboratory studies with a new semisynthetic penicillin. J. Infect. Dis. 127: S97 (1973).

32.       Cole, M., Kenig, M.D., Hewitte, VA.: Metabolism of penicillins to penicilioic acids and 6-aminopenicillamc acid In man and its significance in assessing penicillin absorption. Antib. Ag. Chemoth. 3:463 (1973)

33.       Fishman, L.S., Hewitt, W.L: The natural penicillins. Med. Clin. North Am. 54:1081 (1970)

34.       Rolinson, G.N., Sutherland, R.: Semisynthetic penicillins. Adv, Pharmac. Chemoth. 17:152 (1973)

35.       Moellering, R.C., Swartz, M.N.: The newer cephalosporin. N. Engl. J. Med. 294:24 (1976)

36.       Clara, F.: Profil de la lamoxactame (Moxalactame) première oxacéphamycine à large spectre et à longue durée d’action. Mêd. etfiyg. 40:2009 (1982)

37.       Huthy, R.: Céphalosporines de la 3e génération: pharmacocinétique comparative. Symposium sur les infections à gram-négatifs menaçant le pronostic vital, Zurich, 16.4.1982

38.      Rolio, D.M.: Physiological disposition of some semisynthetir penicillins. Canad. J, Physiol. Pharmacol. 50:986 (1972)

39.       Roberts, M.S., Denton, M.J.; Effect of posture and sleep on pharmacokinetics: I Amoxycillin. Eur. J. Clin. Pharmacol. 75:175 (1980)

40.      Πλέσσας, X.T. Π λύσσας Σ.Τ.: Επίδραση της τροφής στη βιοδιαθεσιμότητα των φαρμάκων. Επ/Θ. Κλιν. Φαρμακολ, Φαρμακοκ. 7:15 (1983)

41.       Barza, Μ,, Weinstein, L: Some determinants of the distribution of penicillins and cephalosporins in the body. Practical and theoretical considerations. Ann. N.Y. Acad. Set. 235:613 (1974)

42.       Craig, W.A., Welling, P.G.: Protein Binding of Antimicrobials: Clinical Pharmacokinetic and Therapeutic Implications. din. Pharmacok. 2:242 (1977)

43.       Gillette, J.R.: Overview of drug-protein binding. Ann. N.Y. Acad. Sci. 226:6 (1973)

44.       Barza, M., Weinstein, L: Pharmacokinetics of the penicillins in man. din. Pharmacok. 7:287 (1976)

45.       Brogard, J.M., Comte, F., Pringet, M.: Pharmacokinetics of cephalosporin antibiotics. Antibiot. Chemother. 25:123 (1978)

46.       Murray, B.E., Moellering, R.C.Jr: Cephalosporins. Ann. Rev. Med. 32:559 (1981)

47.       Guerrero, I.C., McGregor, R.R.: Comparative penetration of various cephalosporins into inflammatory exudate. Anil. microb. Agents Chemother. 15:7\2 (1979)

48.      Barza, M., Weinstein, L.: Penetration of antibiotics into fibrin loci in vivo. I. Comparison of penetration of ampicillin into fibrin clots, abscesses and interstitial fluid! J. infect. Dis. 729:59 (1975)

49.       Schierl, E.A.: Ascitic fluid cephalosporin concetrations; influence of protein binding and serum pharmacokinetics. Antimicrob. Agents Chemother. 74:234 (1978)

50.       Nightingale, C.H., Klimek, J.J., Quintiliani, R.: Effet of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open heart surgical patients. Antimicrob. Agents Chemother. 7 7:595 (1980)

51.       Hogben, C.A.M.: Biological membranes and their passage by drugs. In: Handbook of Experimental Pharmacology (Brodie, Ackerman eds), vol. 29, p. I, Springer-Verlag, New York, 1970

52.       Forbes, M., Becker, B.: The transport of organic anions by the rabbit eye. Am. J. Ophthalmology 50:867 (1960)

53.       Dixon, R.L., Rail, D.P.: Evidence of active transport of benzyl-14C-penicillin from cerebrospinal fluid to blood. J. Pharm. Sci. 55:1106 (1969)

54.       Lerner, P.I.: Penetration of cephaloridine into cerebrospinal fluid. Am. J. Med. Sci. 752:321 (1971)

55.       Steiberg, E.A., Overturf, G.D., Wilkins, J., Baraff, L.J., Streng, J.M., Leedom, J.M.: Failure of cephamandole in treatment of meningitis due to Haemophilus influenza type b. J. infect. Dis. 137 (Suppl.S): 180 (1978).

56.       Hubert, G., Leroy, A., Roger, J.P., Cherubln, C.: Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis. Antimicrob. Agents Chemother. 7 7:675 (1980)

57.       Schaad, U.: Pharmacokinetics and bactetiologic efficacy of moxalactam, cefotaxime, cefoperazone and rocephine in experimental bacterial meningitis. J. Infect. Dis. 743:156 (1981)

58.       Plessas, C.T., Plessas, S.T., Koutsikos, S.D., Manthas, C., Liapis, A.: Pharmacokinetics of cephalexin in man. 4th Eur. Cong. Dis. Chest, Book of abstracts, p,100, Thessaloniki, June 1981

59.       Andriole, V.T.: Pharmacokinetics -of cephalosporins in patients with renal failure or reduced renal function. J. Infect. Dfs. (Suppl. S.) 737:88 (1978)

60.      Dettll, L.: Arzneimiteldosierung bei Niereninsuffizienz, 1979

61.       Aronoff, G.R., Sloan Rebecca, S., Luft, F.C.: Pharmacokinetics of moxalactam in patients with normal and impaired renal function. J. Infect. Dis. 745:365 (1982)

62.       Barza, M., Brusch, J., Bergeron, M.G., Kemmotsu, O., Weinstein, L.: Extraction of antibiotics from the circulation by liver and kindney: effect of probenecid. J. Infect. Dis. 131 (Suppi.): 86 (1975)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr